Allison Inserro

Allison is Associate Editorial Director for The American Journal of Managed Care® (AJMC®) and The Center for Biosimilars®. She joined AJMC® in 2017. She produces and oversees written, video, and podcast content across several disease states and issues surrounding value-based care and health policy.

She has an MPA from New York University. You can connect with Allison on LinkedIn.

Articles by Allison Inserro

The FDA cleared the first generic version of EpiPen and EpiPen Jr, an epinephrine auto-injector for severe allergic reactions, 2 years after generic drugmaker Teva Pharmaceuticals was first turned down in its bid to win approval for the device. The Teva device is the first-ever generic to the one marketed by Mylan, which is still in short supply during the busy back-to-school season in pharmacies due to production issues at Pfizer, which makes the device.

Next week, a CMS committee will hold a day-long meeting to discuss a national coverage determination (NCD) for chimeric antigen receptor (CAR) T-cell immunotherapies, and in Thursday’s New England Journal of Medicine, Peter B. Bach, MD, MAPP, reviewed several strategies open to CMS as it continues to try to determine how to pay for CAR T.

In a test of what could happen as more work requirements are attached as conditions to receiving government health benefits or other forms of government assistance, more than 25% of Medicaid recipients in Arkansas are at risk of losing health insurance for failing to meet work requirements, a recent blog post in Health Affairs said.

A study that sought to replicate the effects of vaping on lung cells found that vapor from e-cigarettes boosts the production of inflammatory chemicals and disables key protective cells in the lung that engulf potentially harmful particles. Some of the effects were similar to those seen in regular smokers and people with chronic obstructive pulmonary disease.

Patients with ductal carcinoma in situ (DCIS) are often treated with radiation after lumpectomy, although it has remained unclear whether this can reduce the risk of dying from this noninvasive form of breast cancer. A new study published Friday said that the combination of the 2 treatments was associated with a small benefit in reduced risk of breast cancer death compared with lumpectomy or mastectomy alone.

CMS is proposing an overhaul for accountable care organizations (ACOs) participating in the Medicare Shared Savings Program by reducing the amount of time an ACO can stay in a 1-sided risk arrangement to 2 years. CMS said it expects to save about $2.24 billion over 10 years even as the number of ACOs drop. CMS is renaming the program "Pathways to Success."

Complementary medicine and alternative medicine (CAM) is estimated to be a multibillion business in the United States, but people who use it instead of conventional cancer treatment have a 2-fold risk of death, a recent study in JAMA Oncology reported. Patients using or considering CAM are unlikely to discuss it with their doctors, who should proactively inform patients of the risk, the study said.

A report from the Office of Inspector General (OIG) at HHS synthesized 10 years of research about the Medicare Hospice Program and found deficiencies in patient care, inappropriate billing, and even fraud. Patients went without pain medicine, hospices did not always provide the right level of care or provided poor quality care, billed for unnecessary care, enrolled people who were not eligible for care, or billed for services that were never provided.

Both asthma and attention-deficit/hyperactivity disorder (ADHD), both chronic conditions, have been associated with each other in previous studies, but questions remained as to the strength of the association because of other possible confounders. A new review of published data, followed by a population-based study, says the association remains after controlling for possible confounders.

The largest genomewide association studies ever completed for osteoporosis identified 899 loci, or regions, in the human genome associated with low bone mineral density, 613 of which have not yet been discovered. The Stanford University School of Medicine researcher who made the finding said that widespread genetic screenings could predict a person's future risk of osteoporosis and bone fracture.

Close to 200 organizations wrote to CMS and HHS this week to express concerns with the Trump administration’s plans to cut millions of dollars from the Affordable Care Act’s marketing and outreach budget, saying that they are “frustrated by CMS’ assertions that the need for these services has decreased as the number of uninsured or underinsured Americans continues to grow.”



Brand Logo

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo